1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Under Armour raised its fiscal 2025 restructuring plan by $95 million to up to $255 million of pre-tax charges to be incurred in fiscal 2025 and 2026, and announced the separation of Curry Brand. Its GAAP fiscal 2026 operating outlook moved from income of $19 million to $34 million to a loss of $56 million to $71 million, while its adjusted operating income outlook rose to $95 million to $110 million. For shareholders, the reported loss outlook reflects the restructuring charges, which the company excludes from its adjusted figures.
Restructuring plan increased by $95 million to up to $255 million, including up to $107 million in cash charges and up to $148 million in non-cash charges
As of September 30, 2025, the company had recognized approximately $147 million of restructuring and related charges ($82 million cash, $65 million non-cash)
GAAP fiscal 2026 operating outlook is a loss of $56 million to $71 million, versus prior income of $19 million to $34 million
Adjusted operating income outlook raised to $95 million to $110 million from $90 million to $105 million
RLI Corp. said Chief Financial Officer Todd Bryant will retire, stepping down from the CFO role on December 31, 2025. Aaron Diefenthaler, the company's Chief Investment Officer & Treasurer since 2012, will succeed him as CFO effective January 1, 2026. The filing does not include financial results, so the change is a leadership transition rather than a change in reported performance.
Todd Bryant will step down as CFO on December 31, 2025, after more than 30 years with the company; he joined in 1993 and has been CFO since 2019.
Bryant will not receive 2026 annual or long-term incentive awards, but will keep his current salary through retirement and an advisory role to support the transition.
Aaron Diefenthaler becomes CFO effective January 1, 2026, with an annual base salary of $400,000 and a preliminary award under the MVP Program.
Dollar General appointed Emily C. Taylor, its executive vice president and chief merchandising officer, as chief operating officer effective November 16, 2025, with a base salary increase to $950,000. The company also eliminated the executive vice president, strategy and development position held by Steven R. Deckard, whose last day was November 12, 2025, and made related changes to its merchandising leadership.
Emily C. Taylor appointed COO effective November 16, 2025; her base salary rises from $850,000 to $950,000 and her targeted cash incentive from 75% to 100% of base salary.
Taylor will receive restricted stock units with an estimated aggregate value of approximately $209,000, vesting ratably over three years.
Bryan Wheeler promoted to executive vice president and chief merchandising officer, succeeding Taylor in that role.
Executive vice president, strategy and development position eliminated; Steven R. Deckard's last day was November 12, 2025.
Matthews International agreed on November 12, 2025 to sell its Warehouse Automation business to Duravant LLC for total consideration of $230 million, including $223.3 million in cash plus assumed liabilities. The company said it will primarily use the net proceeds to significantly reduce debt, and it continues a strategic alternatives review.
Total consideration of $230 million: $223.3 million cash plus assumed liabilities, subject to post-signing adjustments
The business generated sales of $72 million for fiscal 2025 and is part of the Industrial Technologies segment
Net proceeds, after taxes and transaction costs, to be used primarily to significantly reduce outstanding debt
Closing is subject to regulatory approval and expected before the end of fiscal 2026 second quarter; either party may terminate if not closed by January 31, 2026
SAIC announced an internal reorganization that combines its five business groups into three, effective January 31, 2026. Executive Vice President David C. Ray, who leads the Space and Intelligence group, will step down immediately and leave the company on January 30, 2026, and will receive severance in exchange for a release of claims and a two-year non-compete. The filing gives no dollar figures for costs or savings from the restructuring.
Five business groups will be consolidated into three effective January 31, 2026: Army Navy (ANG), Air Force, Space and Intelligence (AFSI), and Civilian
Barbara Supplee will lead ANG, Vinnie DiFronzo will lead AFSI, and Srini Attili will continue to lead Civilian
David C. Ray departs January 30, 2026; Josh Jackson and Chief Innovation Officer Lauren Knausenberger also depart
The Chief Innovation Office will be restructured; the filing gives no dollar figures for restructuring costs or savings
CleanSpark completed a private offering of $1.15 billion in 0.00% convertible senior notes due 2032, with net proceeds of about $1.13 billion. The company used about $460.0 million of those proceeds to repurchase 30.6 million common shares from investors in the offering, which the company says is about 10.9% of shares outstanding. The notes add $1.15 billion of senior unsecured debt, and their conversion price of about $19.16 per share means possible future dilution for shareholders.
Aggregate principal of $1,150,000,000 in 0.00% convertible senior notes maturing February 15, 2032, sold at 100% of principal
Net proceeds of about $1.13 billion; about $460.0 million used to repurchase 30.6 million shares
Initial conversion price of about $19.16 per share; notes not redeemable by the company before February 20, 2029
Remaining proceeds to fund power and land expansion, data center development, repaying bitcoin-backed credit line balances and general corporate purposes
Pfizer said on November 13, 2025 that it completed its acquisition of Metsera, Inc. under a merger agreement dated September 21, 2025, as amended November 7, 2025. Metsera holders receive $65.60 per share in cash at closing, an enterprise value of approximately $7.0 billion, plus contingent value rights worth up to $20.65 per share tied to three milestones. The deal adds Metsera's GLP-1-based weight-loss drug candidates to Pfizer's pipeline, but the milestone payments depend on future clinical and regulatory events.
Closing cash consideration of $65.60 per Metsera share, an enterprise value of approximately $7.0 billion
Contingent value rights of up to $20.65 per share in cash across three milestones
Milestones: $4.60 on Phase 3 trial start for MET-097i+MET-233i; $6.40 on FDA approval of MET-097i monotherapy; $9.65 on FDA approval of the combination
Deal completed November 13, 2025 via Mayfair Merger Sub, Inc., a wholly owned subsidiary
MarineMax reported fiscal 2025 fourth-quarter revenue of $552.2 million, down from $563.1 million a year earlier, and a net loss of $0.9 million, or $0.04 per share, compared with net income of $4.0 million a year earlier. For the full year, the company reported a net loss of $31.6 million after a $69.1 million non-cash goodwill impairment, and it issued fiscal 2026 guidance of $110 million to $125 million in adjusted EBITDA and $0.40 to $0.95 per diluted share in adjusted net income.
Q4 fiscal 2025 adjusted EBITDA was $17.3 million, versus $33.5 million in the prior-year quarter.
Q4 gross margin rose to 34.7% from 34.3%, while SG&A expenses rose to $177.6 million from $166.4 million.
Full-year fiscal 2025 reported loss per share was $1.43; adjusted earnings per share was $0.61 versus $2.13 a year earlier.
Fiscal 2026 guidance: adjusted EBITDA of $110 million to $125 million and adjusted net income of $0.40 to $0.95 per diluted share.
S&P Global held its 2025 Investor Day on November 13, 2025, and announced a new share repurchase program of up to 30 million shares. It also introduced non-GAAP medium-term targets that exclude any contribution from the planned Mobility spin-off, and said it will not give 2026 financial guidance until its fourth-quarter earnings in February 2026.
Medium-term targets, on an average annual basis: 7% to 9% organic, constant currency revenue growth; 50-75 bps adjusted operating margin expansion; double-digit adjusted diluted EPS growth.
New share repurchase program authorized for up to 30 million shares.
A previously announced $2.5 billion accelerated share repurchase is expected to launch in the fourth quarter following Investor Day.
The company reiterated its target of returning approximately 85% of adjusted free cash flow to shareholders through dividends and buybacks.
Disney reported fourth-quarter and full-year fiscal 2025 results for the period ended September 27, 2025. Full-year revenue rose 3% to $94.4 billion and full-year adjusted EPS rose 19% to $5.93, while fourth-quarter revenue was flat and fourth-quarter adjusted EPS fell 3% to $1.11. For fiscal 2026, Disney guided to double-digit adjusted EPS growth and said it plans to double share repurchases to $7 billion.
Full-year diluted EPS was $6.85, up from $2.72; fourth-quarter diluted EPS was $0.73, up from $0.25
Fourth-quarter total segment operating income fell 5% to $3.5 billion from $3.7 billion
Fiscal 2026 guidance includes double-digit adjusted EPS growth and a share repurchase target of $7 billion, double the fiscal 2025 level
Board declared a cash dividend of $1.50 per share, payable in two installments of $0.75 on January 15, 2026 and July 22, 2026
Edgewell Personal Care reported fourth-quarter and fiscal 2025 results on November 13, 2025, with a fourth-quarter GAAP net loss of $30.6 million after a $51.1 million goodwill impairment tied to its Feminine Care business. Fiscal 2025 GAAP EPS was $0.53, down from $1.97, and the company gave fiscal 2026 guidance that excludes the planned $340 million sale of Feminine Care to Essity.
Q4 net sales were $537.2 million, up 3.8%, but the company posted a GAAP net loss of $30.6 million, or $0.66 per diluted share, versus net income of $8.8 million a year earlier.
Q4 included a non-cash goodwill impairment charge of $51.1 million for the Feminine Care reporting unit.
Fiscal 2025 net sales were $2,223.5 million, down 1.3%, and GAAP diluted EPS was $0.53 versus $1.97 in fiscal 2024.
Fiscal 2026 adjusted EPS is expected at $2.15 to $2.55, compared with fiscal 2025 adjusted EPS of $2.52; the outlook excludes the $340 million Feminine Care divestiture to Essity.
Edgewell Personal Care agreed on November 12, 2025 to sell its Feminine Care segment to Essity for $340 million in cash, subject to customary adjustments. The closing is expected in the first quarter of calendar 2026, pending regulatory approvals, and the company expects the sale to reduce its adjusted EPS and adjusted EBITDA on an annualized basis, net of transition service income.
Buyer: Essity Aktiebolag (publ); consideration is $340 million in cash, subject to adjustments for inventory, indebtedness and other items
Expected closing in the first quarter of calendar 2026; the outside date is May 12, 2026, with extensions to as late as November 12, 2026
Company expects an annualized impact of approximately $0.40 to $0.50 in adjusted EPS and $35 million to $45 million in adjusted EBITDA, net of transition services income
Net proceeds, after taxes and transaction costs, are intended primarily to strengthen the balance sheet; the company would receive a $15 million termination fee in certain circumstances
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.